Sales soar for Roche's OTC anti-obesity drug

12/5/2005 | Stuff (New Zealand)

Sales of Roche Holding's anti-obesity drug Xenical have risen 90% in New Zealand since it was made available without prescription six months ago, but a women's group says ads for the drug target people who do not need it. A Roche spokesman said the average size of a person taking Xenical has fallen from a body mass index of 36 to 34 since the drug was given OTC status.

View Full Article in:

Stuff (New Zealand)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA